Sangamo BioSciences And City of Hope Granted Strategic Partnership...

Sangamo BioSciences, Inc. announced that the California Institute for Regenerative Medicine has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic for HIV/AIDS based on the application of Sangamo's zinc finger nuclease genome-editing technology in ... (more)

http://ift.tt/1oC6weq